Vericel Corporation (VCEL) — Stock Score Summary

Vericel Corporation (VCEL) has a MoatMap StockRank of 59/100 based on Quality (64/100), Value (20/100), and Momentum (59/100) factor scores. The current signal is HOLD. Vericel is a specialized cell therapy company with good growth in niche sports medicine markets, but it lacks a clear connection to our core macro themes and does not possess the scale economics of a top-tier compounder.

Vericel Corporation is a commercial-stage biotechnology company specializing in advanced autologous cell therapies for severe medical conditions, primarily focusing on knee cartilage repair (MACI) and burn care (Epicel, NexoBrid). The company maintains a leading position in these niche markets due to its proprietary manufacturing processes, strong clinical evidence, and the high regulatory barriers inherent in cell therapy. Vericel acts as a pioneer in regenerative medicine with a highly specialized product portfolio.

Key Financial Metrics

Price$37.03
Market Cap$1.7B
P/E (TTM)83.00
P/E (Forward)41.89
Price/Book5.11
Return on Equity6.6%
Return on Invested Capital4.1%
Debt/Equity26.68
Gross Margin74.8%
Operating Margin-11.8%
Revenue Growth30.1%
Free Cash Flow$42M

Vericel Corporation operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Vericel Corporation’s (VCEL) StockRank?
MoatMap’s StockRank for Vericel Corporation (VCEL) is 59/100, with a Hold signal. It is a composite of Quality (64), Value (20), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Vericel Corporation have an economic moat?
Vericel Corporation (VCEL) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vericel Corporation a buy, hold, or sell?
MoatMap’s current signal for Vericel Corporation (VCEL) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vericel Corporation in?
Vericel Corporation (VCEL) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVCEL deep dive reportAI ChampionsHow we score stocksSense-check another stock